144 related articles for article (PubMed ID: 33429150)
1. Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
Kimura M; Oda Y; Oishi K; Yoshino K; Kimura H; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Schizophr Res; 2021 Feb; 228():1-6. PubMed ID: 33429150
[TBL] [Abstract][Full Text] [Related]
2. Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats.
Oda Y; Fujita Y; Oishi K; Nakata Y; Takase M; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Psychopharmacology (Berl); 2017 Oct; 234(20):3027-3036. PubMed ID: 28744562
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis.
Oda Y; Tadokoro S; Takase M; Kanahara N; Watanabe H; Shirayama Y; Hashimoto K; Iyo M
J Psychopharmacol; 2015 Dec; 29(12):1308-13. PubMed ID: 26174132
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
Tadokoro S; Okamura N; Sekine Y; Kanahara N; Hashimoto K; Iyo M
Schizophr Bull; 2012 Sep; 38(5):1012-20. PubMed ID: 21402722
[TBL] [Abstract][Full Text] [Related]
5. Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.
Kimura M; Oda Y; Kimura H; Nangaku M; Hirose Y; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Pharmacol Biochem Behav; 2021 Mar; 202():173114. PubMed ID: 33485878
[TBL] [Abstract][Full Text] [Related]
6. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
[TBL] [Abstract][Full Text] [Related]
7. Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in Treatment-Resistant Schizophrenia.
Oda Y; Kanahara N; Iyo M
Int J Mol Sci; 2015 Dec; 16(12):30144-63. PubMed ID: 26694375
[TBL] [Abstract][Full Text] [Related]
8. Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.
Nakata Y; Kanahara N; Iyo M
J Psychopharmacol; 2017 Dec; 31(12):1511-1518. PubMed ID: 28925317
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of heat-shock protein HSP-70 and glutamate transporter-1/glutamine synthetase in the striatum and hippocampus in haloperidol-induced dopamine-supersensitivity-state rats.
Kimura M; Oda Y; Hirose Y; Kimura H; Yoshino K; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Pharmacol Biochem Behav; 2021 Dec; 211():173288. PubMed ID: 34653399
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.
Kanahara N; Takase M; Sasaki T; Honma M; Fujita Y; Tadokoro S; Suzuki H; Yamanaka H; Noda S; Yanahashi S; Saiga T; Komatsu N; Simoyama T; Iyo M
Int Clin Psychopharmacol; 2020 Nov; 35(6):338-344. PubMed ID: 32868522
[TBL] [Abstract][Full Text] [Related]
12. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis.
Iyo M; Tadokoro S; Kanahara N; Hashimoto T; Niitsu T; Watanabe H; Hashimoto K
J Clin Psychopharmacol; 2013 Jun; 33(3):398-404. PubMed ID: 23609386
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
El Hage C; Bédard AM; Samaha AN
Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Asenapine in Drug-resistant Psychotic Patients with Dopamine Supersensitivity Psychosis: Two Cases.
Kanahara N; Kimura H; Kinoshita T; Iyo M; Takekita Y
Clin Psychopharmacol Neurosci; 2023 Feb; 21(1):197-201. PubMed ID: 36700326
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy of modified electroconvulsive therapy and long-acting injectable aripiprazole for dopamine supersensitivity psychosis: a case report.
Matsuzaka Y; Noguchi M; Kanamura S; Maeda K; Hisano T; Tanaka D; Ando Y; Yamamoto T; Morimoto Y; Ozawa H; Otsuka T
Neurocase; 2022 Jun; 28(3):310-313. PubMed ID: 35993136
[TBL] [Abstract][Full Text] [Related]
16. Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
Oishi K; Kanahara N; Takase M; Oda Y; Nakata Y; Niitsu T; Ishikawa M; Sato Y; Iyo M
PLoS One; 2018; 13(11):e0207133. PubMed ID: 30408108
[TBL] [Abstract][Full Text] [Related]
17. Treatment-resistant schizophrenia characterised by dopamine supersensitivity psychosis and efficacy of asenapine.
Takao N; Murai T; Fujiwara H
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33849886
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Treatment With Long-Acting Injectable Antipsychotic in Schizophrenia Patients With and Without Dopamine Supersensitivity Psychosis: A 6-Year Retrospective Comparative Study.
Kogure M; Kanahara N; Kimura M; Hanaoka S; Hirano H; Iyo M
J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):357-364. PubMed ID: 35727084
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.
Chouinard G; Samaha AN; Chouinard VA; Peretti CS; Kanahara N; Takase M; Iyo M
Psychother Psychosom; 2017; 86(4):189-219. PubMed ID: 28647739
[TBL] [Abstract][Full Text] [Related]
20. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
Charron A; Hage CE; Servonnet A; Samaha AN
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
